BMY Bristol Myers Squibb Loading...

From NVDA earnings calls
Loading chart...
Top Calls
Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
0 selected
All Content✓
Source feeds
Buzzberg Top 50 ✓
All market capsNo capitalization filter✓
200 B and aboveMega✓
10 B to 200 BLarge✓
2 B to 10 BMid✓
0 to 2 BSmall✓
Custom
Enter market cap range in B USD
All directions✓
▲ Long✓
▼ Short✓
⛔ Avoid✓
✂ Close✓
◦ Others✓
Any score✓
LOW+✓
MED+✓
HIGH✓
21:00
Aug 26 ◎
Colette Kress CFO, NVIDIA Corporation NVDA Q2 FY27 call
The BMS investment, following Roche and Lilly, signals accelerating AI adoption in pharma and life sciences, a new growth vector for NVIDIA's platform.
BMY
HIGH

About BMY Analyst Coverage

Buzzberg tracks BMY (Bristol Myers Squibb) across 1 sources. 0 bullish vs 0 bearish calls from 1 analysts. Sentiment: evenly split. 1 total trade idea tracked. Past 7 days: 1 watch. Latest voices: Colette Kress.